In a more indirect manner, CTLA-4 targeting could deplete regulatory T-cells within the tumor site in a non-small cell lung cancer in vivo model, by that increasing the cytotoxic functionality of tumor-resident NK cells [105]. The gene discussed is CTLA4; the disease is neoplasm.